Table 1.
Characteristic | Entire Cohort (n = 84,427) | Cases (n = 3,270) | Breast Cancer Incidence Ratea |
Mean age at cohort entry, years | 59.1 (8.8)b | 60.1 (8.5) | |
Race/ethnicity, % | |||
African-American | 18.6 | 19.1 | 336.2 |
Japanese-American | 28.1 | 30.7 | 418.8 |
Latina | 20.5 | 14.7 | 233.7 |
Native Hawaiian | 7.4 | 8.8 | 506.4 |
White | 25.5 | 26.6 | 359.2 |
Body mass indexc, % | |||
<25 | 47.7 | 45.5 | 351.2 |
25–<30 | 31.0 | 32.2 | 347.5 |
≥30 | 21.3 | 22.3 | 363.0 |
Age (years) at menarche, % | |||
≤12 | 49.9 | 51.9 | 369.6 |
13–14 | 38.2 | 37.5 | 348.5 |
≥15 | 11.8 | 10.6 | 292.0 |
Age (years) at first livebirth, % | |||
Nulliparous | 13.0 | 15.8 | 440.3 |
≤20 | 28.9 | 23.1 | 269.1 |
21–25 | 35.1 | 34.3 | 342.2 |
26–30 | 16.3 | 18.5 | 426.5 |
≥31 | 6.7 | 8.3 | 474.4 |
Parityd, % | |||
1 | 13.0 | 14.5 | 407.5 |
2–3 | 51.3 | 55.1 | 368.8 |
≥4 | 35.6 | 30.4 | 272.1 |
Type of menopause, % | |||
None (premenopausal) | 15.2 | 13.0 | 307.9 |
Natural menopause | 53.0 | 57.0 | 366.2 |
Oophorectomy | 14.9 | 13.4 | 285.1 |
Hysterectomy | 16.9 | 16.7 | 341.5 |
Postmenopausal hormone therapy, % | |||
Never use | 52.4 | 45.4 | 316.3 |
Former use | 16.8 | 16.0 | 299.4 |
Current use of estrogen therapy | 14.1 | 14.2 | 329.3 |
Current use of estrogen-progestin therapy | 16.8 | 24.4 | 500.6 |
Alcohol intake (drinks/day), % | |||
0 | 60.8 | 59.0 | 343.8 |
<2 | 33.9 | 33.7 | 349.7 |
≥2 | 5.3 | 7.3 | 487.7 |
First-degree family history of breast cancer, % | |||
No | 88.9 | 82.7 | 330.2 |
Yes | 11.1 | 17.3 | 546.2 |
Incidence rate per 100,000 women; age-adjusted to the 1970 US standard population.
Numbers in parentheses, standard deviation.
Weight (kg)/height (m)2.
Among parous women.